Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Gleevec submitted in U.S. and E.U. for first-line use in CML

July 5, 2002

Heat-activated drug therapy for prostate cancer enters clinical trials

July 5, 2002

Antisoma's vascular targeting agent well tolerated in phase I trials

July 5, 2002

Inhibitors of ubiquitin ligases as potential new anticancer agents

July 5, 2002

Advexin lung cancer patient reaches five-year survival

July 4, 2002

Highly potent prodrug for use in ADEPT of cancer

July 4, 2002

Melanoma vaccine candidate based on bacterial adjuvant protein and MART-1-derived peptide

July 4, 2002

Phase III trials in preparation for Cotara in advanced brain cancer

July 4, 2002

NeoPharm submits IND for LE-SN-38

July 3, 2002

Pretreatment with Genasense being tested for advanced malignant melanoma

July 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...